EWC:NYE-iShares MSCI Canada ETF (USD)

ETF | Miscellaneous Region |

Last Closing

USD 41.45

Change

0.00 (0.00)%

Market Cap

N/A

Volume

2.19M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

Largest Industry Peers for Miscellaneous Region

Symbol Name Price(Change) Market Cap
FLGB Franklin FTSE United Kingdom E..

N/A

USD 0.72B
FLCA Franklin FTSE Canada ETF

N/A

USD 0.41B
EIDO iShares MSCI Indonesia ETF

N/A

USD 0.35B
EPOL iShares MSCI Poland ETF

N/A

USD 0.30B
GREK Global X MSCI Greece ETF

N/A

USD 0.21B
FLKR Franklin FTSE South Korea ETF

N/A

USD 0.12B
EIRL iShares MSCI Ireland ETF

N/A

USD 0.12B
EPHE iShares MSCI Philippines ETF

N/A

USD 0.12B
FLMX Franklin FTSE Mexico ETF

N/A

USD 0.09B
EPU iShares MSCI Peru ETF

N/A

USD 0.08B

ETFs Containing EWC

HEWC 0.00 % 0.03 %

N/A

N/A
BIKR 0.00 % 0.75 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Miscellaneous Region) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.00% 59% D- 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.00% 59% D- 64% D
Trailing 12 Months  
Capital Gain 23.88% 56% F 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.88% 56% F 66% D+
Trailing 5 Years  
Capital Gain 43.43% 71% C- 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 43.43% 71% C- 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 9.49% N/A N/A 67% D+
Dividend Return 11.12% N/A N/A 64% D
Total Return 1.63% N/A N/A 38% F
Risk Return Profile  
Volatility (Standard Deviation) 19.36% N/A N/A 53% F
Risk Adjusted Return 57.46% N/A N/A 74% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike